GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
8IHI | P63096 | Cryo-EM structure of HCA2-Gi complex with acifran | |
8IHI | P62874 | Cryo-EM structure of HCA2-Gi complex with acifran | |
8IHI | P63213 | Cryo-EM structure of HCA2-Gi complex with acifran | |
8IHI | P0ABE7 | Cryo-EM structure of HCA2-Gi complex with acifran | |
8IHI | Q8TDS4 | Cryo-EM structure of HCA2-Gi complex with acifran | |
8IHI | 8IHI | Cryo-EM structure of HCA2-Gi complex with acifran | |
8TO7 | Q2N0S5 | Cryo-EM structure of HERH-b*01 Fab in complex with HIV-1 Env trimer BG505.DS SOSIP | |
8TO7 | 8TO7 | Cryo-EM structure of HERH-b*01 Fab in complex with HIV-1 Env trimer BG505.DS SOSIP | |
8TU9 | Q68CP4 | Cryo-EM structure of HGSNAT-acetyl-CoA complex at pH 7.5 | |
8TU9 | A0A9X4KGN5 | Cryo-EM structure of HGSNAT-acetyl-CoA complex at pH 7.5 | |
8EUU | Q2N0S6 | Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01 FAB | |
8EUU | 8EUU | Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01 FAB | |
8EUV | Q2N0S6 | Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-COMBO1 FAB | |
8EUV | 8EUV | Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-COMBO1 FAB | |
8EUW | Q2N0S6 | Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-MM28 FAB | |
8EUW | 8EUW | Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-MM28 FAB | |
8TOP | Q2N0S6 | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with antibody GPZ6-b.01 targeting the fusion peptide | |
8TOP | 8TOP | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with antibody GPZ6-b.01 targeting the fusion peptide | |
8TNI | Q2N0S6 | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing bi-specific antibody CAP256L-R27 targeting the CD4-binding site and the V2-apex | |
8TNI | 8TNI | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing bi-specific antibody CAP256L-R27 targeting the CD4-binding site and the V2-apex | |
8TNH | Q2N0S6 | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody G36 targeting the CD4-binding site | |
8TNH | 8TNH | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody G36 targeting the CD4-binding site | |
8TNG | Q2N0S6 | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody R27 targeting the CD4-binding site | |
8TNG | 8TNG | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody R27 targeting the CD4-binding site | |
7L6O | A0A1W6IPB2 | Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 | CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp120, CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp41 |
7L6O | 7L6O | Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 | CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp120, CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp41 |
7TFO | A0A6H1VH54 | Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573 | |
7TFO | 7TFO | Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573 | |
7TFO | Q2N0S6 | Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573 | |
8DP1 | Q2N0S6 | Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab | |
8DP1 | 8DP1 | Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab | |
8DOW | A0A1W6IPB2 | Cryo-EM structure of HIV-1 Env(CH848 10.17 DS.SOSIP_DT) in complex with DH1030.1 Fab | |
8DOW | Q2N0S7 | Cryo-EM structure of HIV-1 Env(CH848 10.17 DS.SOSIP_DT) in complex with DH1030.1 Fab | |
8DOW | 8DOW | Cryo-EM structure of HIV-1 Env(CH848 10.17 DS.SOSIP_DT) in complex with DH1030.1 Fab | |
6UM5 | A0A1W6IPB2 | Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain |
6UM5 | Q2N0S7 | Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain |
6UM5 | 6UM5 | Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain |
6UM6 | A0A1W6IPB2 | Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env | Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41 |
6UM6 | Q2N0S7 | Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env | Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41 |
6UM6 | 6UM6 | Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env | Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41 |
6OGE | P04626 | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
6OGE | P01834 | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
6OGE | 6OGE | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
6OGE | P01834 | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
6OGE | 6OGE | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
6OGE | P0DOX5 | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
6OGE | P0DOX5 | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
6OGE | Q6GMX6 | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
6OGE | Q6GMX6 | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
8TR3 | D7S2E5 | Cryo-EM structure of HmAb64 scFv in complex with CNE40 SOSIP trimer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024